Skip to main navigation Skip to search Skip to main content

ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib

  • E Thunnissen
  • , B I Lissenberg-Witte
  • , M M van den Heuvel
  • , K Monkhorst
  • , B G Skov
  • , J B Sørensen
  • , A Mellemgaard
  • , A M C Dingemans
  • , E J M Speel
  • , A J de Langen
  • , S M S Hashemi
  • , I Bahce
  • , M A van der Drift
  • , M G Looijen-Salamon
  • , J Gosney
  • , P E Postmus
  • , S M S Samii
  • , F Duplaquet
  • , B Weynand
  • , X Durando
    • F Penault-Llorca, S Finn, A O Grady, B Oz, N Akyurek, R Buettner, J Wolf, L Bubendorf, S Duin, I Marondel, L C Heukamp, W Timens, E M D Schuuring, P Pauwels, E F Smit
12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib'. Together they form a unique fingerprint.
Sort by

Keyphrases

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Veterinary Science and Veterinary Medicine

Biochemistry, Genetics and Molecular Biology